Cargando…

Disruption of GPR35 Signaling in Bone Marrow-Derived Cells Does Not Influence Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice

G-protein-coupled receptor-35 (GPR35) has been identified as a receptor for the tryptophan metabolite kynurenic acid (KynA) and suggested to modulate macrophage polarization in metabolic tissues. Whether GPR35 can influence vascular inflammation and atherosclerosis has however never been tested. Let...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baumgartner, Roland, Casagrande, Felipe B., Mikkelsen, Randi B., Berg, Martin, Polyzos, Konstantinos A., Forteza, Maria J., Arora, Aastha, Schwartz, Thue W., Hjorth, Siv A., Ketelhuth, Daniel F. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303390/ https://www.ncbi.nlm.nih.gov/pubmed/34201526 http://dx.doi.org/10.3390/metabo11070411

Ejemplares similares

Activation of the Regulatory T-Cell/Indoleamine 2,3-Dioxygenase Axis Reduces Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice
por: Forteza, Maria J., et al.
Publicado: (2018)

Pyruvate dehydrogenase kinase regulates vascular inflammation in atherosclerosis and increases cardiovascular risk
por: Forteza, Maria J, et al.
Publicado: (2023)

Receptor structure-based discovery of non-metabolite agonists for the succinate receptor GPR91
por: Trauelsen, Mette, et al.
Publicado: (2017)

Genetic Deficiency of Indoleamine 2,3-dioxygenase Aggravates Vascular but Not Liver Disease in a Nonalcoholic Steatohepatitis and Atherosclerosis Comorbidity Model
por: Arora, Aastha, et al.
Publicado: (2022)

Type 2 diabetes is associated with increased circulating levels of 3-hydroxydecanoate activating GPR84 and neutrophil migration
por: Mikkelsen, Randi Bonke, et al.
Publicado: (2022)

3-Hydroxyanthralinic acid metabolism controls the hepatic SREBP/lipoprotein axis, inhibits inflammasome activation in macrophages, and decreases atherosclerosis in Ldlr(−/−) mice
por: Berg, Martin, et al.
Publicado: (2019)

Regional Variation in Genetic Control of Atherosclerosis in Hyperlipidemic Mice
por: Jones, Michael B., et al.
Publicado: (2020)

G-Protein-Coupled Receptor 91-Dependent Signalling Does Not Influence Vascular Inflammation and Atherosclerosis in Hyperlipidaemic Mice
por: Griepke, Silke, et al.
Publicado: (2023)

Influence of phthalates on glucose homeostasis and atherosclerosis in hyperlipidemic mice
por: Zhou, Wei, et al.
Publicado: (2015)

The therapeutic potential of orphan GPCRs, GPR35 and GPR55
por: Shore, Derek M., et al.
Publicado: (2015)

Genetic Connection between Hyperglycemia and Carotid Atherosclerosis in Hyperlipidemic Mice
por: Shi, Lisa J., et al.
Publicado: (2022)

Multiple tyrosine metabolites are GPR35 agonists
por: Deng, Huayun, et al.
Publicado: (2012)

GPR35 as a Novel Therapeutic Target
por: MacKenzie, A. E., et al.
Publicado: (2011)

The aromatic amino acid sensor GPR142 controls metabolism through balanced regulation of pancreatic and gut hormones
por: Rudenko, Olga, et al.
Publicado: (2018)

Metabolism in atherosclerotic plaques: immunoregulatory mechanisms in the arterial wall
por: Forteza, Maria J., et al.
Publicado: (2022)

Cortistatin reduces atherosclerosis in hyperlipidemic ApoE-deficient mice and the formation of foam cells
por: Delgado-Maroto, Virginia, et al.
Publicado: (2017)

Effect of Dysferlin Deficiency on Atherosclerosis and Plasma Lipoprotein Composition Under Normal and Hyperlipidemic Conditions
por: White, Zoe, et al.
Publicado: (2021)

Atherosclerosis Susceptibility in Mice Is Independent of the V1 Immunoglobulin Heavy Chain Gene
por: Centa, Monica, et al.
Publicado: (2016)

β-Cell Specific Overexpression of GPR39 Protects against Streptozotocin-Induced Hyperglycemia
por: Egerod, Kristoffer L., et al.
Publicado: (2011)

Hematopoietic miR155 Deficiency Enhances Atherosclerosis and Decreases Plaque Stability in Hyperlipidemic Mice
por: Donners, Marjo M. P. C., et al.
Publicado: (2012)

Urotensin II Enhances Advanced Aortic Atherosclerosis Formation and Delays Plaque Regression in Hyperlipidemic Rabbits
por: Yu, Qingqing, et al.
Publicado: (2023)

The Three Catecholics Benserazide, Catechol and Pyrogallol are GPR35 Agonists
por: Deng, Huayun, et al.
Publicado: (2013)

Lodoxamide Attenuates Hepatic Fibrosis in Mice: Involvement of GPR35
por: Kim, Mi-Jeong, et al.
Publicado: (2020)

GPR35 in Intestinal Diseases: From Risk Gene to Function
por: Kaya, Berna, et al.
Publicado: (2021)

Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment
por: Pagano, Ester, et al.
Publicado: (2022)

G Protein-Coupled Receptor GPR35 Suppresses Lipid Accumulation in Hepatocytes
por: Lin, Li-Chiung, et al.
Publicado: (2021)

Bidirectional GPR119 Agonism Requires Peptide YY and Glucose for Activity in Mouse and Human Colon Mucosa
por: Tough, Iain R, et al.
Publicado: (2018)

BAFF Receptor mAb Treatment Ameliorates Development and Progression of Atherosclerosis in Hyperlipidemic ApoE(−/−) Mice
por: Kyaw, Tin, et al.
Publicado: (2013)

Low-Density Lipoprotein-Reactive T Cells Regulate Plasma Cholesterol Levels and Development of Atherosclerosis in Humanized Hypercholesterolemic Mice
por: Gisterå, Anton, et al.
Publicado: (2018)

Therapeutic Opportunities and Challenges in Targeting the Orphan G Protein-Coupled Receptor GPR35
por: Quon, Tezz, et al.
Publicado: (2020)

Involvement of CXCL17 and GPR35 in Gastric Cancer Initiation and Progression
por: Li, Yizhi, et al.
Publicado: (2022)

GPR35 acts a dual role and therapeutic target in inflammation
por: Wu, Yetian, et al.
Publicado: (2023)

Agonist-induced phosphorylation of orthologues of the orphan receptor GPR35 functions as an activation sensor
por: Divorty, Nina, et al.
Publicado: (2022)

Lipemic serum in hyperlipidemic pancreatitis
por: Michalakis, Konstantinos, et al.
Publicado: (2009)

Defective Fas Expression on Bone Marrow Derived Cells Alters Atherosclerotic Plaque Morphology in Hyperlipidemic Mice
por: Kubo, Nobuhiko, et al.
Publicado: (2015)

Paradoxical effect of a pequi oil-rich diet on the development of atherosclerosis: balance between antioxidant and hyperlipidemic properties
por: Aguilar, E.C., et al.
Publicado: (2012)

High-fructose and high-fat diet-induced insulin resistance enhances atherosclerosis in Watanabe heritable hyperlipidemic rabbits
por: Ning, Bo, et al.
Publicado: (2015)

Ablation of CD8α(+) dendritic cell mediated cross-presentation does not impact atherosclerosis in hyperlipidemic mice
por: Legein, Bart, et al.
Publicado: (2015)

Adipocyte calcium sensing receptor is not involved in visceral adipose tissue inflammation or atherosclerosis development in hyperlipidemic Apoe(−/−) mice
por: Sundararaman, Sai Sahana, et al.
Publicado: (2021)

Phenotypic and Genetic Evidence for a More Prominent Role of Blood Glucose than Cholesterol in Atherosclerosis of Hyperlipidemic Mice
por: Abramson, Ashley M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_75sciate8nuvr4002frr1isarp